Comparison of inhibitory effects between acetaminophen-glutathione conjugate and reduced glutathione in human glutathione reductase

Journal of Applied Toxicology

Volumn 34, Issue 9, 2014, Pages 968-973

  Nýdlová, Erika ^a   Vrbová, Martina ^a   Česla, Petr ^a   Jankovičová, Barbora ^a   Ventura, Karel ^a   Roušar, Tomáš ^a  

^a UNIVERSITY OF PARDUBICE   (Czech Republic)

Author keywords

Acetaminophen toxicity; Glutathione; Glutathione reductase

Indexed keywords

GLUTATHIONE; GLUTATHIONE REDUCTASE; PARACETAMOL; 3-(GLUTATHION-S-YL)ACETAMINOPHEN; GLUTATHIONE DISULFIDE; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG OVERDOSE; ENZYME ACTIVITY; ENZYME INHIBITION; LIVER INJURY; PRIORITY JOURNAL; TOXICITY TESTING; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DOSE RESPONSE; ENZYMOLOGY; ERYTHROCYTE; HUMAN; METABOLISM;

ACETAMINOPHEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; HUMANS; RECOMBINANT PROTEINS;

EID: 84905025772     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2914     Document Type: Article

References (39)

1. Adem S, Ciftci M. 2012. Purification of rat kidney glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and glutathione reductase enzymes using 2', 5'-ADP Sepharose 4B affinity in a single chromatography step. Protein Expr. Purif. 81: 1-4.
2. Arscott LD, Veine DM, Williams CH. 2000. Mixed disulfide with glutathione as an intermediate in the reaction catalyzed by glutathione reductase from yeast and as a major form of the enzyme in the cell. Biochemistry 39: 4711-4721.
3. Becker K, Gui M, Schirmer RH. 1995. Inhibition of human glutathione reductase by S-nitrosoglutathione. Eur. J. Biochem. 234: 472-478.
4. Bessems JGM, Vermeulen NPE. 2001. Paracetamol acetaminophen.-induced toxicity: Molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 31: 55-138.
5. Bradford MM. 1976. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 72: 248-254.
6. Carlberg I, Mannervik B. 1975. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 250: 5475-5480.
7. Chung PM, Cappel RE, Gilbert HF. 1991. Inhibition of glutathione disulfide reductase by glutathione. Arch. Biochem. Biophys. 288: 48-53.
8. Henderson CJ, Wolf CR, Kitteringham N, Powell H, Otto D, Park BK. 2000. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc. Natl. Acad. Sci. U. S. A. 97: 12741-12745.
9. Iwasaki Y, Saito Y, Nakano Y, Mochizuki K, Sakata O, Ito R, Saito K, Nakazawa H. 2009. Chromatographic and mass spectrometric analysis of glutathione in biological samples. J. Chromatogr. B 877: 3309-3317.
10. Jaeschke H, Bajt ML. 2006. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol. Sci. 89: 31-41.
11. Jaeschke H, McGill MR, Williams CD, Ramachandran A. 2011. Current issues with acetaminophen hepatotoxicity-a clinically relevant model to test the efficacy of natural products. Life Sci. 88: 737-745.
12. Karplus PA, Pai EF, Schulz GE. 1989. A crystallographic study of the glutathione binding-site of glutathione-reductase at 0.3-nm resolution. Eur. J. Biochem. 178: 693-703.
13. Lee WM. 2004. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 40: 6-9.
14. Lu SC. 1999. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 13: 1169-1183.
15. Lu SC. 2009. Regulation of glutathione synthesis. Mol. Aspects Med. 30: 42-59.
16. Madsen KG, Olsen J, Skonberg C, Hansen SH, Jurva U. 2007. Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: Correlation to in vitro drug metabolism. Chem. Res. Toxicol. 20: 821-831.
17. Mannervik B, Jacobsson K, Boggaram V. 1976. Purification of glutathione reductase from erythrocytes by use of affinity chromatography on 2', 5'-ADP-Sepharose 4-B. FEBS Lett. 66: 221-224.
18. Meister A, Anderson ME. 1983. Glutathione. Annu. Rev. Biochem. 52: 711-760.
19. Nydlova E, Rousar T. 2011. Assessment of glutathione reductase inhibition. Sci. Pap. Univ. Pardubice 17: 77-83.
20. Pastore A, Federici G, Bertini E, Piemonte F. 2003. Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 333: 19-39.
21. Rescigno M, Perham RN. 1994. Structure of the NADPH-binding motif of glutathione-reductase-efficiency determined by evolution. Biochemistry 33: 5721-5727.
22. Ritter D, Knebel JW, Aufderheide M, Mohr U. 1999. Development of a cell culture model system for routine testing of substances inducing oxidative stress. Toxicol. In Vitro 13: 745-751.
23. Rousar T, Cervinkova Z, Muzakova V, Kucera O, Lotkova H, Krivakovaa P. 2005. [Glutathione and glutathione assays]. Acta Medica (Hradec Kralove) Suppl. 48: 15-20.
24. Rousar T, Parik P, Kucera O, Bartos M, Cervinkova Z. 2010. Glutathione reductase is inhibited by acetaminophen-glutathione conjugate in vitro. Physiol. Res. 59: 225-232.
25. Rousar T, Nydlova E, Cesla P, Stankova P, Kucera O, Parik P, Cervinkova Z. 2012. Purified acetaminophen-glutathione conjugate is able to induce oxidative stress in rat liver mitochondria. Phys. Res. 61: S103-S109.
26. Rzucidlo SJ, Bounous DI, Jones DP, Brackett BG. 2000. Acute acetaminophen toxicity in transgenic mice with elevated hepatic glutathione. Vet. Hum. Toxicol. 42: 146-150.
27. Seefeldt T, Zhao Y, Chen W, Raza AS, Carlson L, Herman J, Stoebner A, Hanson S, Foll R, Guan X. 2009. Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J. Biol. Chem. 284, 2729-2737.
28. Senturk M, Talaz O, Ekinci D, Cavdar H, Kufrevioglu OI. 2009. In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates. Bioorg. Med. Chem. Lett. 19: 3661-3663.
29. Sexton DJ, Mutus B. 1992. Glutathione reductases from a variety of sources are inhibited by physiological levels of glutathione. Comp. Biochem. Phys. B 103: 897-901.
30. Styblo M, Serves SV, Cullen WR, Thomas DJ. 1997. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10, 27-33.
31. Sweet WL, Blanchard JS. 1991. Human erythrocyte glutathione-reductase-chemical mechanism and structure of the transition-state for hydride transfer. Biochemistry 30: 8702-8709.
32. Thatcher NJ, Murray S. 2001. Analysis of the glutathione conjugate of paracetamol in human liver microsomal fraction by liquid chromatography mass spectrometry. Biomed. Chromatogr. 15, 374-378.
33. Toribio F, Alhama J, Lopez-Barea J. 1996. Methods for chromatographic and electrophoretic separation and assay of NADP oxidoreductases. J. Chromatogr. B Biomed. Appl. 684: 1-23.
34. Townsend DM, Tew KD, Tapiero H. 2003. The importance of glutathione in human disease. Biomed. Pharmacother. 57: 145-155.
35. Ulusu NN, Tandogan B. 2007. Purification and kinetic properties of glutathione reductase from bovine liver. Mol. Cell. Biochem. 303: 45-51.
36. Vander Jagt DL, Hunsaker LA, Vander Jagt TJ, Gomez MS, Gonzales DM, Deck LM, Royer RE. 1997. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem. Pharmacol. 53: 1133-1140.
37. Vessey DA, Lee KH. 1993. Inactivation of enzymes of the glutathione antioxidant system by treatment of cultured human keratinocytes with peroxides. J. Invest. Dermatol. 100: 829-833.
38. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. 2004. Glutathione metabolism and its implications for health. J. Nutr. 134: 489-492.
39. Zhao Y, Seefeldt T, Chen W, Wang XQ, Matthees D, Hu YS, Guan XM. 2009. Effects of glutathione reductase inhibition on cellular thiol redox state and related systems. Arch. Biochem. Biophys. 485, 56-62.